OBJECTIVE: There is limited information on the acceptability and safety of praziquantel for treatment of schistosomiasis in children below the age of four years. In addition, although mebendazole has been extensively used together with praziquantel against infections with schistosomiasis and soil-transmitted helminthiasis (STH) in school-aged children, no specific acceptability or safety studies have been published on this drug combination in younger children. METHODS: A randomized clinical trial was conducted to determine the safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and STH in children aged 1 to 4 years. RESULTS: A total of 596 children from Bwondha fishing community in Mayuge district and Wang-Kado fishing community in Nebbi district were investigated using duplicate Kato-Katz thick smears of two stool samples and 130 (21·8%) were found infected with S. mansoni. Of these, 19·2% (25) had heavy intensity of infections. Of the infected children, 82 were included and randomised into praziquantel (40 mg/kg) + mebendazole (500 mg) or praziquantel (40 mg/kg) alone. CONCLUSION: Many symptoms were reported before treatment while very few were reported after treatment and all on treatment day. No serious adverse events were reported or observed after treatment. Praziquantel with or without mebendazole was well tolerated in small children in the study area.
RCT Entities:
OBJECTIVE: There is limited information on the acceptability and safety of praziquantel for treatment of schistosomiasis in children below the age of four years. In addition, although mebendazole has been extensively used together with praziquantel against infections with schistosomiasis and soil-transmitted helminthiasis (STH) in school-aged children, no specific acceptability or safety studies have been published on this drug combination in younger children. METHODS: A randomized clinical trial was conducted to determine the safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and STH in children aged 1 to 4 years. RESULTS: A total of 596 children from Bwondha fishing community in Mayuge district and Wang-Kado fishing community in Nebbi district were investigated using duplicate Kato-Katz thick smears of two stool samples and 130 (21·8%) were found infected with S. mansoni. Of these, 19·2% (25) had heavy intensity of infections. Of the infected children, 82 were included and randomised into praziquantel (40 mg/kg) + mebendazole (500 mg) or praziquantel (40 mg/kg) alone. CONCLUSION: Many symptoms were reported before treatment while very few were reported after treatment and all on treatment day. No serious adverse events were reported or observed after treatment. Praziquantel with or without mebendazole was well tolerated in small children in the study area.
Authors: Stephanie M Davis; Ryan E Wiegand; Fridah Mulama; Edmund Ireri Kareko; Robert Harris; Elizabeth Ochola; Aaron M Samuels; Fredrick Rawago; Pauline M Mwinzi; LeAnne M Fox; Maurice R Odiere; Kimberly Y Won Journal: Am J Trop Med Hyg Date: 2015-03-09 Impact factor: 2.345
Authors: Jean T Coulibaly; Yves K N'Gbesso; Nicaise A N'Guessan; Mirko S Winkler; Jürg Utzinger; Eliézer K N'Goran Journal: Am J Trop Med Hyg Date: 2013-05-20 Impact factor: 2.345
Authors: Jean T Coulibaly; Yve K N'gbesso; Stefanie Knopp; Jennifer Keiser; Eliézer K N'Goran; Jürg Utzinger Journal: PLoS Negl Trop Dis Date: 2012-12-06
Authors: J Russell Stothard; José C Sousa-Figueiredo; Martha Betson; Helen K Green; Edmund Y W Seto; Amadou Garba; Moussa Sacko; Francisca Mutapi; Susana Vaz Nery; Mutamad A Amin; Margaret Mutumba-Nakalembe; Annalan Navaratnam; Alan Fenwick; Narcis B Kabatereine; Albis F Gabrielli; Antonio Montresor Journal: Parasitology Date: 2011-08-24 Impact factor: 3.234
Authors: Jean T Coulibaly; Gordana Panic; Kigbafori D Silué; Jana Kovač; Jan Hattendorf; Jennifer Keiser Journal: Lancet Glob Health Date: 2017-07 Impact factor: 26.763
Authors: Manuel Lemos; Joao M Pedro; Cláudia Fançony; Sofia Moura; Miguel Brito; Susana Vaz Nery; Carlos Pinto Sousa; Henrique Barros Journal: PLoS One Date: 2020-03-11 Impact factor: 3.240